Organovo Holdings, Inc. (ONVO)

[rumper]

Used ToGet A BuckOrTwo OutOf A Positive Article

Now it looks like nothing will come of it, at all.

This company needs to release all positives.
And get inside the decision cycle of the shorts.
Start throwing fast balls every pitch.

It needs to walk the walk.

The talk just isn't getting it done.

Any discussion of printing human organs immediately
changes the focus to a decade or more in the future.
The FDA process take ten years, AFTER they actually
print an organ.

They need to change the entire focus of the company
from 3D printing to diagnostic biotechnology.

It's time to stop with the nerd fantasy and focus on bucks.
And the money ball is toxicity testing.